- Home
- VGZ vs FENC Comparison
VGZ vs FENC Comparison
Compare VGZ & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGZ
- FENC
- Stock Information
- Founded
- VGZ 1983
- FENC 1996
- Country
- VGZ United States
- FENC United States
- Employees
- VGZ N/A
- FENC N/A
- Industry
- VGZ
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VGZ
- FENC Health Care
- Exchange
- VGZ Nasdaq
- FENC Nasdaq
- Market Cap
- VGZ 143.6M
- FENC 156.9M
- IPO Year
- VGZ N/A
- FENC 2001
- Fundamental
- Price
- VGZ $0.98
- FENC $8.31
- Analyst Decision
- VGZ Strong Buy
- FENC Strong Buy
- Analyst Count
- VGZ 1
- FENC 2
- Target Price
- VGZ $2.75
- FENC $13.00
- AVG Volume (30 Days)
- VGZ 1.2M
- FENC 114.2K
- Earning Date
- VGZ 07-28-2025
- FENC 05-13-2025
- Dividend Yield
- VGZ N/A
- FENC N/A
- EPS Growth
- VGZ N/A
- FENC N/A
- EPS
- VGZ 0.08
- FENC N/A
- Revenue
- VGZ N/A
- FENC $30,912,000.00
- Revenue This Year
- VGZ N/A
- FENC N/A
- Revenue Next Year
- VGZ N/A
- FENC $59.17
- P/E Ratio
- VGZ $12.52
- FENC N/A
- Revenue Growth
- VGZ N/A
- FENC N/A
- 52 Week Low
- VGZ $0.46
- FENC $3.96
- 52 Week High
- VGZ $1.30
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- VGZ 44.48
- FENC 66.40
- Support Level
- VGZ $0.95
- FENC $7.63
- Resistance Level
- VGZ $1.28
- FENC $8.72
- Average True Range (ATR)
- VGZ 0.08
- FENC 0.45
- MACD
- VGZ -0.03
- FENC -0.02
- Stochastic Oscillator
- VGZ 17.95
- FENC 64.69
About VGZ Vista Gold Corp
Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.